Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PAICSP7 stands for "phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase pseudogene 7." It is classified as a **pseudogene**, meaning it is a segment of DNA that resembles a gene but is typically nonfunctional and not transcribed into a functional protein product. Its sequence is related to enzymes involved in **purine biosynthesis**, but as a pseudogene, it does not contribute to these enzymatic activities or any known therapeutic function. Pseudogenes are not considered active molecular targets for drug discovery or therapeutic intervention. If you are seeking information on a genuine metabolic enzyme target, consider related functional genes such as **PAICS** (phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase), which is an enzyme involved in purine biosynthesis. However, PAICSP7 itself is a **nonfunctional pseudogene** and not a viable therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase pseudogene 7 (PAICSP7).